Parcell Laboratories, founded in 2008, is dedicated to advancing regenerative medicine through its unique adult stem cell platform technology, the ELA® cell. Discovered by scientists affiliated with Brigham and Women’s Hospital and Harvard Medical School, ELA cells are distinguished by a specific surface marker profile and are found in various tissues throughout the body. The company's mission is to develop novel therapeutics leveraging these cells to address a range of medical conditions.

Notable individuals associated with Parcell Laboratories include researchers from prestigious institutions like Harvard Medical School. The company has attracted significant interest from investors focused on cutting-edge medical technologies. Key achievements include demonstrating the vast potential of ELA cells in regenerative medicine, positioning Parcell Laboratories as a leader in the field. Their innovative approach has had a considerable impact on the development of new treatments, contributing to advancements in healthcare and offering hope for patients with previously untreatable conditions.